TaiwanProduct Registration for Medical Devices in Taiwan
Taevas Global helps medical devices manufacturers achieve TFDA product registration in Taiwan with precision, speed, and full regulatory compliance. From device classification to license issuance, we manage every step so you can focus on your market entry
Six Pillars of Taiwan Medical Devices Intelligence
Our six interconnected service pillars give medical devices manufacturers a complete, end-to-end foundation for successful product registration and market entry in Taiwan.
Device Classification and Regulatory Pathway
Taiwan classifies medical devices into Class I, II, and III under the Medical Devices Act enforced by TFDA. We assess your device against TFDA classification rules, identify the correct risk category, and map the fastest compliant registration pathway. Understanding classification upfront prevents costly resubmissions and delays.
From Brief to Board-Ready Intelligence
Our structured four-step engagement moves from initial device assessment through to a complete, submission-ready registration package and stakeholder-ready market entry strategy.
Device and Market Assessment
We begin with a comprehensive intake of your device technical file, intended use, and existing international registrations. Our regulatory specialists perform an initial TFDA classification assessment and identify any immediate compliance gaps. This scoping exercise defines the registration pathway, estimated timeline, and resource requirements for your specific device.
You provide product specifications, existing certifications such as CE or FDA clearance, and your target Taiwan launch timeline. We cross-reference TFDA's medical device classification schedules, review any analogous registered products in Taiwan's device database, and deliver a written pathway assessment memo within three business days. This memo becomes the foundation of your Taiwan regulatory strategy.
Taiwan Medical Devices Market at a Glance
Advanced Manufacturing Hub
Taiwan is one of Asia's leading medical device manufacturing and export hubs, with particular strength in diagnostics, imaging equipment, and orthopedic devices. The island's robust semiconductor and electronics ecosystem has driven rapid growth in connected health and digital diagnostic devices. Foreign manufacturers benefit from a sophisticated local supply chain and a technically literate regulatory environment.
TFDA Alignment with International Standards
TFDA has progressively aligned its medical device regulatory framework with international standards including ISO 13485, ISO 14971, and IEC 62304 for software. Taiwan's Medical Devices Act, fully enacted in 2021, modernized the regulatory landscape and introduced risk-based classification consistent with IMDRF principles. Manufacturers with CE marking or FDA clearance often find significant documentation overlap, reducing preparation time.
National Health Insurance as a Market Gateway
Taiwan's National Health Insurance program covers over 99 percent of the population and is a primary procurement channel for medical devices used in clinical settings. Securing NHI reimbursement listing is often as strategically important as obtaining TFDA registration for devices targeting hospital and clinic markets. Understanding NHI pricing and coverage categories is essential to building a viable commercial model in Taiwan.
Growing Demand for High-Tech and Digital Devices
Taiwan's aging population and government investment in smart healthcare are driving strong demand for high-value medical devices including AI-assisted diagnostics, remote monitoring systems, and minimally invasive surgical tools. TFDA has established specific guidance for software as a medical device reflecting the growing importance of digital health products. This creates significant opportunity for innovative foreign manufacturers with differentiated technology.
Everything in Your Report
Your Product Registration engagement with Taevas Global produces a complete set of regulatory, strategic, and commercial deliverables designed to take your medical device from application to approved market entry in Taiwan.
TFDA Regulatory Pathway Assessment
A written memo confirming your device's TFDA classification, applicable registration pathway, estimated review timeline, and key regulatory risks. This document serves as the strategic foundation for your entire Taiwan registration project.
Complete Technical Dossier Package
A fully compiled and reviewed technical file meeting current TFDA submission requirements, including device description, risk management documentation, clinical evidence, and quality system certificates. All documents are formatted and indexed per TFDA guidance.
Competitive Device Registration Analysis
A structured review of competitor and analogous devices registered with TFDA, including license status, device class, and indication scope. This analysis informs your classification strategy and helps anticipate TFDA reviewer expectations.
Regulatory Compliance Gap Report
A detailed gap analysis comparing your existing technical documentation against TFDA requirements, with prioritized remediation actions and responsibility assignments. This report prevents submission delays caused by missing or non-compliant documentation.
Authorized Agent and Legal Entity Guidance
A briefing on Taiwan's authorized agent requirements under the Medical Devices Act, including a shortlist of vetted agent candidates and a contract review checklist. Proper agent structuring protects your license and post-market obligations.
TFDA Submission and Correspondence File
A complete archive of all submission documents, TFDA correspondence, supplemental information responses, and approval records. This file supports future license renewals, variations, and regulatory audits.
Post-Market Surveillance Plan Template
A TFDA-compliant post-market surveillance plan template tailored to your device class, covering adverse event reporting, field safety corrective actions, and periodic safety update reporting schedules. This plan is ready for immediate implementation upon license issuance.
Market Entry Readiness Briefing
A stakeholder-ready briefing deck covering Taiwan market opportunity, NHI reimbursement pathway options, recommended distribution channels, and competitive positioning for your registered device. Designed for presentation to executive and commercial leadership teams.
Built for These Situations
Foreign Manufacturer Entering Taiwan for the First Time
You have CE marking or FDA clearance and are ready to expand into Taiwan but have no existing TFDA experience or local regulatory infrastructure. The unfamiliar classification system, Traditional Chinese documentation requirements, and authorized agent obligations create significant uncertainty. You need a partner who can manage the entire process end-to-end while keeping your internal team informed and in control.
After Product Registration, Most Clients Move To
Common Questions
Ready to Map Your Taiwan Opportunity?
Taevas Global's medical devices regulatory and market entry specialists are ready to assess your device, define your TFDA registration pathway, and build the strategy that gets you to market in Taiwan with confidence.